|
||||||||||||||||||
|
|
||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe purified mouse CCL19-Fc is a fusion protein of the mouse CCL19 chemokine with the human Fcγ fragment. The purified mouse CCL19-Fc can be used for the detection of mouse CCR7 expression when used with a fluorochrome-conjugated anti-human Fc antibody. CCR7 is a chemokine receptor for the chemokines CCL19 (CKβ11, ELC, MIP3β, Scya19, Exodus-3) and CCL21 (CKβ9, SLC, MIP2β, Scya21, Exodus-2). In recent years, the role of chemokines in directing the migration of lymphocytes has been well-characterized. One of the most important mediators of homeostatic trafficking of naïve T cells to secondary lymphoid organs (SLO) is the chemokine receptor CCR7. Binding of its ligands, CCL19 and CCL21, mediates the transendothelial migration of T cells across high endothelial venules into SLO. It has also been demonstrated that CCR7 plays a role in the localization of dendritic cells and B cells during an immune response. In addition to its significant role in the chemotaxis of lymphocytes, human CCR7 has also been recognized as a marker for a distinct subset of memory T cells, the central memory (TCM) population. These cells are characterized by the expression of CCR7 and CD62L and reside within peripheral lymphoid organs. CCR7 also plays a role in thymocyte development and its deficiency leads to disturbed thymic architecture, aberrant T cell development, and limited thymocyte expansion. Applications ReportedFor research use only, not for diagnostic or therapeutic use. Purified Mouse CCL19-Fc has been reported for use in flow cytometric analysis. Applications TestedRecombinant purified mouse CCL19-Fc has been tested by flow cytometric analysis of mouse splenocytes and thymocytes. This can be used at less than or equal to 0.06 μg per million cells in a 100 μl total staining volume. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. References
Hargreaves DC, Hyman PL, Lu TT, Ngo VN, Bidgol A, Suzuki G, Zou YR, Littman DR, Cyster JG. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med. 2001 Jul 2;194(1):45-56. Misslitz A, Pabst O, Hintzen G, Ohl L, Kremmer E, Petrie HT, Forster R. Thymic T cell development and progenitor localization depend on CCR7. J Exp Med. 2004 Aug 16;200(4):481-91. Junt T, Scandella E, Forster R, Krebs P, Krautwald S, Lipp M, Hengartner H, Ludewig B. Impact of CCR7 on priming and distribution of antiviral effector and memory CTL. J Immunol. 2004 Dec 1;173(11):6684-93. Related ProductsCat. 12-1971 Phycoerythrin (PE) anti-mouse CCR7 (CD197, EBI-1) (clone 4B12) Cat. 13-1971 Biotin anti-mouse CCR7 (CD197, EBI-1) (clone 4B12) Cat. 14-1971 Affinity Purified anti-mouse CCR7 (CD197, EBI-1) (clone 4B12) Cat. 17-1971 Allophycocyanin (APC) anti-mouse CCR7 (CD197, EBI-1) (clone 4B12) Cat. 25-1971 Phycoerythrin-Cy7 (PE-Cy7) anti-mouse CCR7 (CD197, EBI-1) (clone 4B12) Cat. 12-4998 Phycoerythrin (PE) Anti-Human IgG Fcg Fragment Specific, Minimal Reactivity to Mouse IgG (clone Polyclonal) Cat. 13-4998 Biotin Anti-Human IgG Fcg Fragment Specific, Minimal Reactivity to Mouse IgG (clone Polyclonal) Purified Mouse CCL19-Fc Staining Protocol:
|
|||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |